Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Sales | 8,463,105 | 8,341,830 | 8,784,000 | 8,429,699 | 8,419,104 |
| Cost of Goods | 2,252,460 | 2,704,350 | 1,972,000 | 2,345,970 | 2,400,370 |
| Gross Profit | 6,555,370 | 7,733,061 | 5,546,000 | 6,468,130 | 6,340,200 |
| Operating Expenses | 4,816,860 | 6,146,961 | 3,955,000 | 5,006,790 | 4,962,540 |
| Operating Income | 1,394,245 | -509,131 | 2,857,000 | 1,077,909 | 1,056,563 |
| Interest Expense | 131,080 | 146,690 | 123,000 | 180,260 | 212,600 |
| Other Income | 1,021,775 | 1,466,241 | -1,887,000 | -169,029 | 61,587 |
| Pre-tax Income | 2,284,940 | 810,420 | 847,000 | 728,620 | 905,550 |
| Income Tax | 542,370 | 152,630 | 141,000 | 98,320 | 202,100 |
| Net Income Continuous | 1,818,936 | 542,870 | 2,342,400 | 1,957,727 | 696,672 |
| Net Income | $1,818,936 | $542,870 | $2,342,400 | $1,957,727 | $696,672 |
| EPS Basic Total Ops | 0.67 | 0.20 | 1.76 | 0.73 | 0.52 |
| EPS Basic Continuous Ops | 0.67 | 0.20 | 1.76 | 0.73 | 0.52 |
| EPS Diluted Total Ops | 0.67 | 0.20 | 1.76 | 0.73 | 0.52 |
| EPS Diluted Continuous Ops | 0.67 | 0.20 | 1.76 | 0.73 | 0.52 |
| EBITDA(a) | $1,394,245 | $-509,131 | $2,857,000 | $1,077,909 | $1,056,563 |